TCM
GILD icon

TimesSquare Capital Management’s Gilead Sciences GILD Stock Holding History

TimesSquare Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,000
Closed -$726K – 205
2021
Q4 		$726K Hold
10,000
– – 0.01% 200
2021
Q3 		$699K Sell
10,000
-3,115
-24% -$219K 0.01% 210
2021
Q2 		$903K Buy
+13,115
New +$876K 0.01% 208
2015
Q2 		– Sell
-42,845
Closed -$4.2M – 258
2015
Q1 		$4.2M Buy
+42,845
New +$4.35M 0.02% 244

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TimesSquare Capital Management's GILD Position: Q1 2022 in Review

TimesSquare Capital Management sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 10,000 shares — an estimated $726K sold.

TimesSquare Capital Management first reported a position in GILD in Q1 2015 and held it in 4 quarters. The position peaked at $4.2M in Q1 2015. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • TimesSquare Capital Management reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • TimesSquare Capital Management sold 10,000 Gilead Sciences shares in Q1 2022, an estimated $726K.
  • TimesSquare Capital Management first reported a position in Gilead Sciences in Q1 2015 and held it in 4 quarters.
  • TimesSquare Capital Management's Gilead Sciences position peaked at $4.2M in Q1 2015.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on TimesSquare Capital Management's 13F filing for Q1 2022, filed 6 May 2022.